These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 24691581)

  • 21. Neurochemical biomarkers in the differential diagnosis of movement disorders.
    Mollenhauer B; Trenkwalder C
    Mov Disord; 2009 Jul; 24(10):1411-26. PubMed ID: 19412961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New advances in tau imaging in parkinsonism.
    Valli M; Strafella AP
    Int Rev Psychiatry; 2017 Dec; 29(6):628-635. PubMed ID: 29206491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders.
    Constantinescu R; Rosengren L; Johnels B; Zetterberg H; Holmberg B
    Parkinsonism Relat Disord; 2010 Feb; 16(2):142-5. PubMed ID: 19647470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid biomarkers of central catecholamine deficiency in Parkinson's disease and other synucleinopathies.
    Goldstein DS; Holmes C; Sharabi Y
    Brain; 2012 Jun; 135(Pt 6):1900-13. PubMed ID: 22451506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical parkinsonism: an update.
    Stamelou M; Hoeglinger GU
    Curr Opin Neurol; 2013 Aug; 26(4):401-5. PubMed ID: 23812308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal Fluid Galectin-1 Levels Discriminate Patients with Parkinsonism from Controls.
    Marques TM; van Rumund A; Bruinsma IB; Wessels HJCT; Gloerich J; Esselink RAJ; Bloem BR; Kuiperij HB; Verbeek MM
    Mol Neurobiol; 2019 Jul; 56(7):5067-5074. PubMed ID: 30465235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lower urinary tract dysfunction in Parkinsonian syndromes.
    Vichayanrat E; Hentzen C; Batla A; Simeoni S; Iodice V; Panicker JN
    Neurol Sci; 2021 Oct; 42(10):4045-4054. PubMed ID: 34318363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.
    Santaella A; Kuiperij HB; van Rumund A; Esselink RAJ; van Gool AJ; Bloem BR; Verbeek MM
    BMC Neurol; 2020 Jan; 20(1):26. PubMed ID: 31952511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.
    Savoiardo M
    Neurol Sci; 2003 May; 24 Suppl 1():S35-7. PubMed ID: 12774211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive testing in the diagnosis of parkinsonian disorders: a critical appraisal of the literature.
    Lee W; Williams DR; Storey E
    Mov Disord; 2012 Sep; 27(10):1243-54. PubMed ID: 22890580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF-neurofilament and levodopa tests combined with discriminant analysis may contribute to the differential diagnosis of Parkinsonian syndromes.
    Holmberg B; Johnels B; Ingvarsson P; Eriksson B; Rosengren L
    Parkinsonism Relat Disord; 2001 Sep; 8(1):23-31. PubMed ID: 11472877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical diagnostic criteria in Parkinson's disease and parkinsonian syndromes: review of the literature].
    Vercueil L
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():14-22. PubMed ID: 10916032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of atypical Parkinson syndromes.
    Höglinger GU; Kassubek J; Csoti I; Ehret R; Herbst H; Wellach I; Winkler J; Jost WH
    J Neural Transm (Vienna); 2017 Aug; 124(8):997-1004. PubMed ID: 28243754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dystonia in atypical parkinsonian disorders.
    Marsili L; Bologna M; Kojovic M; Berardelli A; Espay AJ; Colosimo C
    Parkinsonism Relat Disord; 2019 Sep; 66():25-33. PubMed ID: 31443953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The DJ-1 concentration in cerebrospinal fluid does not differentiate among Parkinsonian syndromes.
    Salvesen L; Bech S; Lokkegaard A; Hjermind LE; Nielsen JE; Pakkenberg B; Tanassi JT; Heegaard NH; Winge K
    Parkinsonism Relat Disord; 2012 Aug; 18(7):899-901. PubMed ID: 22503539
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.